A Mutant Receptor Tyrosine Phosphatase, CD148, Causes Defects in Vascular Development

REFERENCES

• Adams, R. H. 2002. Vascular patterning by Eph receptor tyrosine kinases and ephrins. Semin. Cell Dev. Biol. 13: 55–60.
   PubMed Web of Science ®Google Scholar
• Baker, J. E., R. Majeti, S. G. Tangye, and A. Weiss. 2001. Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cγ1 phosphorylation. Mol. Cell. Biol. 21: 2393–2403.
   PubMedGoogle Scholar
• Barbara, N. P., J. L. Wrana, and M. Letarte. 1999. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J. Biol. Chem. 274: 584–594.
   PubMed Web of Science ®Google Scholar
• Begley, C. G., P. D. Aplan, S. M. Denning, B. F. Haynes, T. A. Waldmann, and I. R. Kirsch. 1989. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA 86: 10128–10132.
   PubMed Web of Science ®Google Scholar
• Bi, W., C. J. Drake, and J. J. Schwarz. 1999. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 211: 255–267.
   PubMedGoogle Scholar
• Bianchi, C., F. W. Sellke, R. L. Del Vecchio, N. K. Tonks, and B. G. Neel. 1999. Receptor-type protein-tyrosine phosphatase mu is expressed in specific vascular endothelial beds in vivo. Exp. Cell Res. 248: 329–338.
   PubMed Web of Science ®Google Scholar
• Borges, L. G., R. A. Seifert, F. J. Grant, C. E. Hart, C. M. Disteche, S. Edelhoff, F. F. Solca, M. A. Lieberman, V. Lindner, E. H. Fischer, S. Lok, and D. F. Bowen-Pope. 1996. Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cells. Circ. Res. 79: 570–580.
   PubMed Web of Science ®Google Scholar
• Bourdeau, A., D. J. Dumont, and M. Letarte. 1999. A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Investig. 104: 1343–1351.
   PubMed Web of Science ®Google Scholar
• Brady-Kalnay, S. M., D. L. Rimm, and N. K. Tonks. 1995. Receptor protein tyrosine phosphatase PTPμ associates with cadherins and catenins in vivo. J. Cell Biol. 130: 977–986.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6: 389–395.
   PubMed Web of Science ®Google Scholar
• Daniel, T. O., and D. Abrahamson. 2000. Endothelial signal integration in vascular assembly. Annu. Rev. Physiol. 62: 649–671.
   PubMed Web of Science ®Google Scholar
• de la Fuente-Garcia, M. A., J. M. Nicolas, J. H. Freed, E. Palou, A. P. Thomas, R. Vilella, J. Vives, and A. Gaya. 1998. CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91: 2800–2809.
   PubMedGoogle Scholar
• Desai, C. J., Q. Sun, and K. Zinn. 1997. Tyrosine phosphorylation and axon guidance: of mice and flies. Curr. Opin. Neurobiol. 7: 70–74.
   PubMedGoogle Scholar
• Drake, C. J., S. J. Brandt, T. C. Trusk, and C. D. Little. 1997. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev. Biol. 192: 17–30.
   PubMed Web of Science ®Google Scholar
• Drake, C. J., and P. A. Fleming. 2000. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95: 1671–1679.
   PubMed Web of Science ®Google Scholar
• Drake, C. J., A. LaRue, N. Ferrara, and C. D. Little. 2000. VEGF regulates cell behavior during vasculogenesis. Dev. Biol. 224: 178–188.
   PubMed Web of Science ®Google Scholar
• Fachinger, G., U. Deutsch, and W. Risau. 1999. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18: 5948–5953.
   PubMed Web of Science ®Google Scholar
• Ferrara, N. 2001. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 280: C1358–C1366.
   PubMed Web of Science ®Google Scholar
• Godwin, A. R., H. S. Stadler, K. Nakamura, and M. R. Capecchi. 1998. Detection of targeted GFP-Hox gene fusions during mouse embryogenesis. Proc. Natl. Acad. Sci. USA 95: 13042–13047.
   PubMedGoogle Scholar
• Hadjantonakis, A. K., M. Gertsenstein, M. Ikawa, M. Okabe, and A. Nagy. 1998. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech. Dev. 76: 79–90.
   PubMed Web of Science ®Google Scholar
• Hellstrom, M., H. Gerhardt, M. Kalen, X. Li, U. Eriksson, H. Wolburg, and C. Betsholtz. 2001. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153: 543–553.
   PubMed Web of Science ®Google Scholar
• Hirschi, K. K., S. A. Rohovsky, and P. A. D'Amore. 1997. Cell-cell interactions in vessel assembly: a model for the fundamentals of vascular remodelling. Transplant Immunol. 5: 177–178.
   PubMedGoogle Scholar
• Jones, N., K. Iljin, D. J. Dumont, and K. Alitalo. 2001. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2: 257–267.
   PubMed Web of Science ®Google Scholar
• Jonker, L., and H. M. Arthur. 2002. Endoglin expression in early development is associated with vasculogenesis and angiogenesis. Mech. Dev. 110: 193–196.
   PubMed Web of Science ®Google Scholar
• Jung, S., J. Aliberti, P. Graemmel, M. J. Sunshine, G. W. Kreutzberg, A. Sher, and D. R. Littman. 2000. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20: 4106–4114.
   PubMed Web of Science ®Google Scholar
• Kallianpur, A. R., J. E. Jordan, and S. J. Brandt. 1994. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83: 1200–1208.
   PubMed Web of Science ®Google Scholar
• Keane, M. M., G. A. Lowrey, S. A. Ettenberg, M. A. Dayton, and S. Lipkowitz. 1996. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 56: 4236–4243.
   PubMed Web of Science ®Google Scholar
• Krebs, L. T., Y. Xue, C. R. Norton, J. R. Shutter, M. Maguire, J. P. Sundberg, D. Gallahan, V. Closson, J. Kitajewski, R. Callahan, G. H. Smith, K. L. Stark, and T. Gridley. 2000. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14: 1343–1352.
   PubMed Web of Science ®Google Scholar
• Kume, T., T. Watanabe, R. Sanokawo, D. Chida, T. Nakamura, and M. Oishi. 1996. Expression of the protein tyrosine phosphatase β2 gene in mouse erythroleukemia cells induces terminal erythroid differentiation. J. Biol. Chem. 271: 30916–30921.
   PubMedGoogle Scholar
• Kuramochi, S., S. Matsuda, Y. Matsuda, T. Saitoh, M. Ohsugi, and T. Yamamoto. 1996. Molecular cloning and characterization of Byp, a murine receptor-type tyrosine phosphatase similar to human DEP-1. FEBS Lett. 378: 7–14.
   PubMedGoogle Scholar
• Li, C., I. N. Hampson, L. Hampson, P. Kumar, C. Bernabeu, and S. Kumar. 2000. CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells. FASEB J. 14: 55–64.
   PubMed Web of Science ®Google Scholar
• Li, D. Y., L. K. Sorensen, B. S. Brooke, L. D. Urness, E. C. Davis, D. G. Taylor, B. B. Boak, and D. P. Wendel. 1999. Defective angiogenesis in mice lacking endoglin. Science 284: 1534–1537.
   PubMed Web of Science ®Google Scholar
• Lindahl, P., H. Bostrom, L. Karlsson, M. Hellstrom, M. Kalen, and C. Betsholtz. 1999. Role of platelet-derived growth factors in angiogenesis and alveogenesis. Curr. Top. Pathol. 93: 27–33.
   PubMedGoogle Scholar
• Oh, S. P., T. Seki, K. A. Goss, T. Imamura, Y. Yi, P. K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim, and E. Li. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97: 2626–2631.
   PubMed Web of Science ®Google Scholar
• Oshima, M., H. Oshima, and M. M. Taketo. 1996. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179: 297–302.
   PubMed Web of Science ®Google Scholar
• Ostman, A., Q. Yang, and N. K. Tonks. 1994. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA 91: 9680–9684.
   PubMed Web of Science ®Google Scholar
• Papetti, M., and I. M. Herman. 2002. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282: C947–C970.
   PubMed Web of Science ®Google Scholar
• Pereira, F. A., Y. Qiu, G. Zhou, M. J. Tsai, and S. Y. Tsai. 1999. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 13: 1037–1049.
   PubMed Web of Science ®Google Scholar
• Piston, D. W., G. H. Patterson, and S. M. Knobel. 1999. Quantitative imaging of the green fluorescent protein (GFP). Methods Cell Biol. 58: 31–48.
   PubMedGoogle Scholar
• Ruivenkamp, C. A., T. Van Wezel, C. Zanon, A. P. Stassen, C. Vlcek, T. Csikos, A. M. Klous, N. Tripodis, A. Perrakis, L. Boerrigter, P. C. Groot, J. Lindeman, W. J. Mooi, G. A. Meijjer, G. Scholten, H. Dauwerse, V. Paces, N. Van Zandwijk, G. J. Van Ommen, and P. Demant. 2002. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat. Genet. 31: 295–300.
   PubMedGoogle Scholar
• Sap, J., Y.-P. Jiang, D. Friedlander, M. Grumet, and J. Schlessinger. 1994. Receptor tyrosine phosphatase R-PTP-κ mediates homophilic binding. Mol. Cell. Biol. 14: 1–9.
   PubMed Web of Science ®Google Scholar
• Schlaeger, T. M., Y. Qin, Y. Fujiwara, J. Magram, and T. N. Sato. 1995. Vascular endothelial cell lineage-specific promoter in transgenic mice. Development 121: 1089–1098.
   PubMedGoogle Scholar
• Suzuki, E., D. Nagata, M. Yoshizumi, M. Kakoki, A. Goto, M. Omata, and Y. Hirata. 2000. Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor. Possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 275: 3637–3644.
   PubMed Web of Science ®Google Scholar
• Takahashi, N., A. Haba, F. Matsuno, and B. K. Seon. 2001. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Cancer Res. 61: 7846–7854.
   PubMed Web of Science ®Google Scholar
• Takahashi, T., K. Takahashi, R. Mernaugh, V. Drozdoff, C. Sipe, H. Schoecklmann, B. Robert, D. R. Abrahamson, and T. O. Daniel. 1999. Endothelial localization of receptor tyrosine phosphatase, ECRTP/DEP-1, in developing and mature renal vasculature. J. Am. Soc. Nephrol. 10: 2135–2145.
   PubMedGoogle Scholar
• Takahashi, Y., T. Imanaka, and T. Takano. 1996. Spatial and temporal pattern of smooth muscle cell differentiation during development of the vascular system in the mouse embryo. Anat. Embryol. (Berlin) 194: 515–526.
   PubMedGoogle Scholar
• Trapasso, F., R. Iuliano, A. Boccia, A. Stella, R. Visconti, P. Bruni, G. Baldassarre, M. Santoro, G. Viglietto, and A. Fusco. 2000. Rat protein tyrosine phosphatase η suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27Kip1. Mol. Cell. Biol. 20: 9236–9246.
   PubMedGoogle Scholar
• Van Vactor, D. 1998. Protein tyrosine phosphatases in the developing nervous system. Curr. Opin. Cell Biol. 10: 174–181.
   PubMedGoogle Scholar
• Wang, H. U., Z. F. Chen, and D. J. Anderson. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741–753.
   PubMed Web of Science ®Google Scholar
• Wartenberg, M., J. Gunther, J. Hescheler, and H. Sauer. 1998. The embryoid body as a novel in vitro assay system for antiangiogenic agents. Lab. Investig. 78: 1301–1314.
   PubMedGoogle Scholar
• Xue, Y., X. Gao, C. E. Lindsell, C. R. Norton, B. Chang, C. Hicks, M. Gendron-Maguire, E. B. Rand, G. Weinmaster, and T. Gridley. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8: 723–730.
   PubMed Web of Science ®Google Scholar
• Yagi, T., S. Nada, N. Watanabe, H. Tamemoto, N. Kohmura, Y. Ikawa, and S. Aizawa. 1993. A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal. Biochem. 214: 77–86.
   PubMedGoogle Scholar
• Zhang, L., M. L. Martelli, C. Battaglia, F. Trapasso, D. Tramontano, G. Viglietto, A. Porcellini, M. Santoro, and A. Fusco. 1997. Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. Exp. Cell Res. 235: 62–70.
   PubMed Web of Science ®Google Scholar
• Zhao, G. Q., K. Deng, P. A. Labosky, L. Liaw, and B. L. Hogan. 1996. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev. 10: 1657–1669.
   PubMed Web of Science ®Google Scholar